טוען...

USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3

BACKGROUND: Cholangiocarcinoma represents the second most common primary liver malignancy. The incidence rate has constantly increased over the last decades. Cholangiocarcinoma silent nature limits early diagnosis and prevents efficient treatment. METHODS: Immunoblotting and immunohistochemistry wer...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	J Biomed Sci
Main Authors:	Chen, Weiqian, Song, Jingjing, Liu, Siyu, Tang, Bufu, Shen, Lin, Zhu, Jinyu, Fang, Shiji, Wu, Fazong, Zheng, Liyun, Qiu, Rongfang, Chen, Chunmiao, Gao, Yang, Tu, Jianfei, Zhao, Zhongwei, Ji, Jiansong
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BioMed Central 2021
נושאים:	Research
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC8191029/ https://ncbi.nlm.nih.gov/pubmed/34112167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-021-00738-2
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3

פריטים דומים